BR9913446A - Produtos de aglicona e métodos de uso - Google Patents
Produtos de aglicona e métodos de usoInfo
- Publication number
- BR9913446A BR9913446A BR9913446-2A BR9913446A BR9913446A BR 9913446 A BR9913446 A BR 9913446A BR 9913446 A BR9913446 A BR 9913446A BR 9913446 A BR9913446 A BR 9913446A
- Authority
- BR
- Brazil
- Prior art keywords
- glycoconjugates
- methods
- aglycone
- products
- aglycone products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
"PRODUTOS DE AGLICONA E MéTODOS DE USO". Glicoconjugados, composições terapêuticas contendo os glicoconjugados e métodos terapêuticos para o uso dos glicoconjugados são revelados, em particular, constituintes de peptídeos de aglicona 10B, que são epítopos imunogênicos responsáveis pelo reconhecimento de antígenos por parte do sistema imunológico, são fornecidos. Estes glicoconjugados são úteis na prevenção da ligação do vírus da gripe às células, no tratamento da esquizofrenia e no diagnóstico de doença viral crónica associada ao desenvolvimento do câncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/146,755 US6242578B1 (en) | 1994-02-17 | 1998-09-04 | Aglyco products and methods of use |
PCT/US1999/019836 WO2000018351A2 (en) | 1998-09-04 | 1999-08-30 | Aglyco products and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9913446A true BR9913446A (pt) | 2004-03-02 |
Family
ID=22518867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9913446-2A BR9913446A (pt) | 1998-09-04 | 1999-08-30 | Produtos de aglicona e métodos de uso |
Country Status (13)
Country | Link |
---|---|
US (4) | US6242578B1 (pt) |
EP (2) | EP1990058A1 (pt) |
JP (2) | JP2004515202A (pt) |
KR (1) | KR100451446B1 (pt) |
CN (2) | CN1328286C (pt) |
AT (1) | ATE406175T1 (pt) |
AU (1) | AU771836B2 (pt) |
BR (1) | BR9913446A (pt) |
CA (1) | CA2341763C (pt) |
DE (1) | DE69939430D1 (pt) |
IL (3) | IL141775A0 (pt) |
NZ (4) | NZ556151A (pt) |
WO (1) | WO2000018351A2 (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7176275B2 (en) * | 1998-09-04 | 2007-02-13 | Samuel Bogoch | Anthrax and small pox replikins and methods of use |
DE10034712A1 (de) * | 2000-07-17 | 2002-02-07 | Arimedes Biotechnology Gmbh | Verbrückte Glykokonjugate |
US7442761B2 (en) | 2003-06-06 | 2008-10-28 | Samuel Bogoch | Replikin peptides and uses thereof |
US7420028B2 (en) | 2001-03-27 | 2008-09-02 | Samuel Bogoch | Replikins and methods of identifying replikin-containing sequences |
US7452963B2 (en) * | 2001-03-27 | 2008-11-18 | Samuel Bogoch | Replikin peptides and antibodies therefore |
JP2004535171A (ja) | 2001-03-27 | 2004-11-25 | ボゴーク,サミュエル | レプリキンペプチドおよびその使用 |
US7189800B2 (en) * | 2001-03-27 | 2007-03-13 | Samuel Bogoch | Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
US7894999B2 (en) | 2001-03-27 | 2011-02-22 | Samuel Bogoch | Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds |
US7774144B2 (en) * | 2001-10-26 | 2010-08-10 | Samuel Bogoch | System and method for identifying complex patterns of amino acids |
KR100906102B1 (ko) | 2001-03-27 | 2009-07-07 | 사무엘 보고치 | 레플리킨 펩타이드 및 그의 이용 |
KR100986104B1 (ko) | 2001-07-09 | 2010-10-07 | 엘레노어 에스 보고치 | 레플리킨 펩타이드 및 그의 이용 |
JP2006500001A (ja) * | 2001-07-09 | 2006-01-05 | ボゴーク,サミュエル | レプリキンペプチドとその使用 |
US7306919B1 (en) | 2001-10-31 | 2007-12-11 | Thornthwaite Jerry T | Antigen-antibody cancer recognition system |
CN100556546C (zh) * | 2003-02-13 | 2009-11-04 | 贝克顿·迪金森公司 | 在血液收集过程中去除成分的装置及其使用 |
US8494781B2 (en) * | 2003-06-06 | 2013-07-23 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
US9254315B2 (en) | 2004-04-28 | 2016-02-09 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
US9002652B1 (en) * | 2005-01-27 | 2015-04-07 | Institute For Systems Biology | Methods for identifying and using organ-specific proteins in blood |
SG160327A1 (en) | 2005-02-16 | 2010-04-29 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
US9820986B2 (en) * | 2005-03-04 | 2017-11-21 | Taiwan Hopaz Chems, Mfg. Co., Ltd. | Glycopeptide compositions |
JP2006288670A (ja) * | 2005-04-11 | 2006-10-26 | Terumo Corp | カテーテル |
WO2008140557A2 (en) * | 2006-10-24 | 2008-11-20 | Samuel Bogoch | A method of predicting influenza outbreaks |
CA2676028A1 (en) * | 2007-01-18 | 2008-11-27 | Samuel Bogoch | Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
US20100105634A1 (en) * | 2007-03-07 | 2010-04-29 | Cargill, Incorporated | Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer |
AU2008266702A1 (en) * | 2007-05-30 | 2008-12-24 | Elenore S. Bogoch | Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
US20090269367A1 (en) * | 2008-04-23 | 2009-10-29 | Samuel Bogoch | Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
US20100144589A1 (en) * | 2008-08-08 | 2010-06-10 | Samuel Bogoch | Methods of predicting cancer lethality using replikin counts |
US9233148B2 (en) | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
EP2734226A2 (en) | 2011-07-20 | 2014-05-28 | Samuel Bogoch | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4298590A (en) * | 1975-02-25 | 1981-11-03 | Samuel Bogoch | Detection of malignant tumor cells |
US4840915A (en) * | 1975-02-25 | 1989-06-20 | Brain Research, Inc. | Method for diagnosing malignant tumors |
US4041146A (en) * | 1975-05-01 | 1977-08-09 | General Electric Company | Method for detection of biological particles |
US4486538A (en) * | 1978-07-07 | 1984-12-04 | Samuel Bogoch | Detection of malignant tumor cells |
US5280113A (en) | 1989-08-16 | 1994-01-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
GB9202219D0 (en) | 1992-02-03 | 1992-03-18 | Connaught Lab | A synthetic heamophilus influenzae conjugate vaccine |
AU2289195A (en) * | 1995-04-11 | 1996-10-30 | Elenore S. Bogoch | Aglyco products |
-
1998
- 1998-09-04 US US09/146,755 patent/US6242578B1/en not_active Expired - Lifetime
-
1999
- 1999-08-30 NZ NZ556151A patent/NZ556151A/en not_active IP Right Cessation
- 1999-08-30 JP JP2000571873A patent/JP2004515202A/ja not_active Withdrawn
- 1999-08-30 WO PCT/US1999/019836 patent/WO2000018351A2/en active Application Filing
- 1999-08-30 IL IL14177599A patent/IL141775A0/xx active IP Right Grant
- 1999-08-30 CN CNB998124745A patent/CN1328286C/zh not_active Expired - Fee Related
- 1999-08-30 EP EP08014504A patent/EP1990058A1/en not_active Withdrawn
- 1999-08-30 AT AT99944002T patent/ATE406175T1/de not_active IP Right Cessation
- 1999-08-30 AU AU56986/99A patent/AU771836B2/en not_active Ceased
- 1999-08-30 CA CA2341763A patent/CA2341763C/en not_active Expired - Fee Related
- 1999-08-30 EP EP99944002A patent/EP1115418B1/en not_active Expired - Lifetime
- 1999-08-30 CN CNA2007101087746A patent/CN101096382A/zh active Pending
- 1999-08-30 DE DE69939430T patent/DE69939430D1/de not_active Expired - Lifetime
- 1999-08-30 KR KR10-2001-7002866A patent/KR100451446B1/ko not_active IP Right Cessation
- 1999-08-30 NZ NZ533511A patent/NZ533511A/en not_active IP Right Cessation
- 1999-08-30 BR BR9913446-2A patent/BR9913446A/pt not_active IP Right Cessation
- 1999-08-30 NZ NZ544362A patent/NZ544362A/en not_active IP Right Cessation
- 1999-08-30 NZ NZ510921A patent/NZ510921A/en not_active IP Right Cessation
-
2001
- 2001-03-04 IL IL141775A patent/IL141775A/en not_active IP Right Cessation
- 2001-03-27 US US09/817,144 patent/US6638505B2/en not_active Expired - Fee Related
-
2003
- 2003-08-19 US US10/642,587 patent/US7381411B2/en not_active Expired - Fee Related
-
2008
- 2008-04-11 US US12/101,292 patent/US20080241859A1/en not_active Abandoned
- 2008-07-08 IL IL192679A patent/IL192679A/en not_active IP Right Cessation
-
2010
- 2010-11-26 JP JP2010263994A patent/JP2011087589A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL192679A0 (en) | 2009-02-11 |
CN101096382A (zh) | 2008-01-02 |
US6638505B2 (en) | 2003-10-28 |
WO2000018351A3 (en) | 2000-07-13 |
US6242578B1 (en) | 2001-06-05 |
US20080241859A1 (en) | 2008-10-02 |
DE69939430D1 (de) | 2008-10-09 |
KR20010072517A (ko) | 2001-07-31 |
NZ544362A (en) | 2008-05-30 |
JP2011087589A (ja) | 2011-05-06 |
NZ533511A (en) | 2006-08-31 |
CA2341763A1 (en) | 2000-04-06 |
EP1115418A4 (en) | 2004-06-09 |
EP1115418B1 (en) | 2008-08-27 |
CN1324258A (zh) | 2001-11-28 |
AU5698699A (en) | 2000-04-17 |
EP1990058A1 (en) | 2008-11-12 |
IL141775A (en) | 2008-11-26 |
EP1115418A2 (en) | 2001-07-18 |
US20040077532A1 (en) | 2004-04-22 |
ATE406175T1 (de) | 2008-09-15 |
IL141775A0 (en) | 2002-03-10 |
NZ556151A (en) | 2009-03-31 |
AU771836B2 (en) | 2004-04-01 |
IL192679A (en) | 2011-10-31 |
NZ510921A (en) | 2004-09-24 |
CA2341763C (en) | 2014-01-21 |
KR100451446B1 (ko) | 2004-10-06 |
CN1328286C (zh) | 2007-07-25 |
WO2000018351A2 (en) | 2000-04-06 |
US20030023047A1 (en) | 2003-01-30 |
JP2004515202A (ja) | 2004-05-27 |
US7381411B2 (en) | 2008-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913446A (pt) | Produtos de aglicona e métodos de uso | |
DE69637642D1 (de) | Und kombinierte zusammensetzungen und deren verwendung | |
BRPI0010612B8 (pt) | vacinas | |
TR199801722T2 (xx) | Peptit imm�nojenler. | |
BR0207283A (pt) | Anticorpos anti-egfr modificados com imunogenicidade reduzida | |
BR9814487A (pt) | "vacina" | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
BRPI0508813B8 (pt) | vacinas líquidas de combinação com baixa dose de conjugado de hib | |
WO1998008542A3 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
GB2255093A (en) | Hiv-1 core protein fragments | |
IL138424A (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
ZA936629B (en) | Potentiation of immunogenic response | |
WO1999032634A3 (en) | Compositions derived from mycobacterium vaccae and methods for their use | |
BR0010711A (pt) | Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes | |
PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao | |
DE60141297D1 (de) | Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper | |
ATE375514T1 (de) | Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion | |
EP1820514A3 (en) | Therapeutic compositions that produce an immune response by altering the antigen | |
BR9911601A (pt) | Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores | |
ATE310750T1 (de) | Verotoxin b untereinheit zur immunisierunug | |
DK0852623T3 (da) | Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler | |
BRPI0409321A (pt) | antìgeno hìbrido, competição e método para induzir uma resposta imune para um agente infeccioso ou antìgeno de tumor, método para tratar uma doença infecciosa ou cáncer, e, peptìdeo | |
BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
SE8803062L (sv) | Sekvensiella polypeptider med immunologisk aktivitet | |
DK0542895T3 (da) | Krydsreaktiv influenza A immunisering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 25 E 37 DA LPI |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2321 DE 30-06-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |